4-nitropyridine 1-oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID Source	ID
PubMed CID	14300
CHEMBL ID	3187617
SCHEMBL ID	768956
MeSH ID	M0061522

Synonyms (51)

Synonym
nsc-130895
AC-5155
4-nitropyridine n-oxide
wln: t6nj ao dnw
1124-33-0
4-nitropyridine-n-oxide
p-nitropyridine n-oxide
nsc5079
4-nitropyridine oxide
4-nitropyridine 1-oxide
nsc-5079
4-(hydroxy(oxido)amino)-1lambda~5~-pyridin-1-ol
nsc130895
4-nitro-1-oxido-pyridin-1-ium
AB-323/25048155
pyridine-1-oxide, 4-nitro-
pyridine, 4-nitro-, 1-oxide
AKOS000281983
4-nitro-1-oxidopyridin-1-ium
N0410
STK801375
NCGC00248141-01
ulb29z652d ,
4-nitropyridine-1-oxide
tox21_300690
NCGC00254598-01
cas-1124-33-0
dtxcid7021524
dtxsid9041524 ,
BBL009979
4-nitropyridin-1-ium-1-olate
FT-0619296
AB00617
pyridine, 4-nitro-, 1-oxide [hsdb]
4-nitro-pyridine n-oxide
4-nitro-pyridine-n-oxide
RXKNNAKAVAHBNK-UHFFFAOYSA-N
4-nitropyridin-1-oxide
SCHEMBL768956
STR00842
Q-101515
CHEMBL3187617
mfcd00006206
F1905-6987
BCP16314
Q230018
2-butenoic acid, 2-cyano-3-(2-methylphenyl)-, ethyl ester
EN300-16691
CS-0128813
4-nitropyridine-d4n-oxide
Z56755636

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (21)

Potency Measurements

Protein	Taxonomy	Measurement	Average (µ)	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
RAR-related orphan receptor gamma	Mus musculus (house mouse)	Potency	11.4294	0.0060	38.0041	19,952.5996	AID1159521; AID1159523
SMAD family member 2	Homo sapiens (human)	Potency	61.6448	0.1737	34.3047	61.8120	AID1346924
SMAD family member 3	Homo sapiens (human)	Potency	61.6448	0.1737	34.3047	61.8120	AID1346924
GLI family zinc finger 3	Homo sapiens (human)	Potency	29.7654	0.0007	14.5928	83.7951	AID1259368; AID1259369; AID1259392
AR protein	Homo sapiens (human)	Potency	50.8490	0.0002	21.2231	8,912.5098	AID1259243; AID1259247; AID743054; AID743063
estrogen receptor 2 (ER beta)	Homo sapiens (human)	Potency	55.9333	0.0006	57.9133	22,387.1992	AID1259377; AID1259378
nuclear receptor subfamily 1, group I, member 3	Homo sapiens (human)	Potency	43.8415	0.0010	22.6508	76.6163	AID1224838; AID1224839; AID1224893
estrogen-related nuclear receptor alpha	Homo sapiens (human)	Potency	31.0374	0.0015	30.6073	15,848.9004	AID1224848; AID1224849; AID1259403
pregnane X nuclear receptor	Homo sapiens (human)	Potency	76.9588	0.0054	28.0263	1,258.9301	AID1346982
estrogen nuclear receptor alpha	Homo sapiens (human)	Potency	60.6686	0.0002	29.3054	16,493.5996	AID1259244; AID1259248; AID1259383; AID743069; AID743078; AID743079; AID743080; AID743091
peroxisome proliferator-activated receptor delta	Homo sapiens (human)	Potency	27.5357	0.0010	24.5048	61.6448	AID743215
peroxisome proliferator activated receptor gamma	Homo sapiens (human)	Potency	48.9662	0.0010	19.4141	70.9645	AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptor	Homo sapiens (human)	Potency	54.9410	0.0237	23.2282	63.5986	AID743223
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a	Homo sapiens (human)	Potency	68.5896	0.0017	23.8393	78.1014	AID743083
thyroid stimulating hormone receptor	Homo sapiens (human)	Potency	76.9588	0.0016	28.0151	77.1139	AID1259385
v-jun sarcoma virus 17 oncogene homolog (avian)	Homo sapiens (human)	Potency	46.3037	0.0578	21.1097	61.2679	AID1159526; AID1159528
Histone H2A.x	Cricetulus griseus (Chinese hamster)	Potency	71.3009	0.0391	47.5451	146.8240	AID1224845
thyroid hormone receptor beta isoform 2	Rattus norvegicus (Norway rat)	Potency	68.5896	0.0003	23.4451	159.6830	AID743065; AID743067
nuclear factor erythroid 2-related factor 2 isoform 1	Homo sapiens (human)	Potency	30.6379	0.0006	27.2152	1,122.0200	AID743202
Voltage-dependent calcium channel gamma-2 subunit	Mus musculus (house mouse)	Potency	54.4827	0.0015	57.7890	15,848.9004	AID1259244
Glutamate receptor 2	Rattus norvegicus (Norway rat)	Potency	54.4827	0.0015	51.7393	15,848.9004	AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Process	via Protein(s)	Taxonomy
plasma membrane	Glutamate receptor 2	Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay ID	Title	Year	Journal	Article
AID1871190	Inhibition of biofilm formation in Pseudomonas aeruginosa at 100 uM measured after 48 hrs relative to control	2021	RSC medicinal chemistry, Dec-15, Volume: 12, Issue:12	2-Difluoromethylpyridine as a bioisosteric replacement of pyridine-
AID1754674	Inhibition of quorum sensing system in Chromobacterium violaceum ATCC 31532 assessed as reduction in violacein production at 100 uM	2021	Bioorganic & medicinal chemistry letters, 08-15, Volume: 46	Discovery of novel β-turn mimetic-based peptides as novel quorum sensing inhibitors of gram-negative bacteria.
AID1871192	Activation of protease (unknown origin)	2021	RSC medicinal chemistry, Dec-15, Volume: 12, Issue:12	2-Difluoromethylpyridine as a bioisosteric replacement of pyridine-
AID1871189	Inhibition of quorum sensing system in Pseudomonas aeruginosa transfected with lasB-gfp	2021	RSC medicinal chemistry, Dec-15, Volume: 12, Issue:12	2-Difluoromethylpyridine as a bioisosteric replacement of pyridine-
AID1754676	Antibiofilm activity against Pseudomonas aeruginosa PA14 assessed as inhibition of biofilm formation at 15 to 50 uM measured after 48 hrs	2021	Bioorganic & medicinal chemistry letters, 08-15, Volume: 46	Discovery of novel β-turn mimetic-based peptides as novel quorum sensing inhibitors of gram-negative bacteria.
AID1436366	Inhibition of quorum sensing system in Agrobacterium tumefaciens harboring traG-LacZ reporter fusion measured after 4 hrs by beta-galactosidase reporter gene assay	2017	European journal of medicinal chemistry, Jan-27, Volume: 126	Fusaric acid and analogues as Gram-negative bacterial quorum sensing inhibitors.
AID1754673	Inhibition of quorum sensing system lasB in Pseudomonas aeruginosa transfected with lasB-gfp assessed as reduction of GFP production	2021	Bioorganic & medicinal chemistry letters, 08-15, Volume: 46	Discovery of novel β-turn mimetic-based peptides as novel quorum sensing inhibitors of gram-negative bacteria.
AID1871191	Inhibition of quorum sensing system in Chromobacterium violaceum ATCC 31352 assessed as reduction in violacein production at 100 uM relative to control	2021	RSC medicinal chemistry, Dec-15, Volume: 12, Issue:12	2-Difluoromethylpyridine as a bioisosteric replacement of pyridine-
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	2 (14.29)	18.7374
1990's	1 (7.14)	18.2507
2000's	3 (21.43)	29.6817
2010's	6 (42.86)	24.3611
2020's	2 (14.29)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	12.28 (24.57)
Research Supply Index	2.71 (2.92)
Research Growth Index	4.99 (4.65)
Search Engine Demand Index	0.00 (26.88)
Search Engine Supply Index	0.00 (0.95)

This Compound (12.28)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	14 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
fusaric acid Fusaric Acid: A picolinic acid derivative isolated from various Fusarium species. It has been proposed for a variety of therapeutic applications but is primarily used as a research tool. Its mechanisms of action are poorly understood. It probably inhibits DOPAMINE BETA-HYDROXYLASE, the enzyme that converts dopamine to norepinephrine. It may also have other actions, including the inhibition of cell proliferation and DNA synthesis.	2.15	1	aromatic carboxylic acid; pyridines
patulin Patulin: 4-Hydroxy-4H-furo(3,2-c)pyran-2(6H)-one. A mycotoxin produced by several species of Aspergillus and Penicillium. It is found in unfermented apple and grape juice and field crops. It has antibiotic properties and has been shown to be carcinogenic and mutagenic and causes chromosome damage in biological systems.. patulin : A furopyran and lactone that is (2H-pyran-3(6H)-ylidene)acetic acid which is substituted by hydroxy groups at positions 2 and 4 and in which the hydroxy group at position 4 has condensed with the carboxy group to give the corresponding bicyclic lactone. A mycotoxin produced by several species of Aspergillus and Penicillium, it has antibiotic properties but has been shown to be carcinogenic and mutagenic.	2.03	1	furopyran; gamma-lactone; lactol	antimicrobial agent; Aspergillus metabolite; carcinogenic agent; mutagen; mycotoxin; Penicillium metabolite
4-nitroquinoline-1-oxide 4-nitroquinoline N-oxide : A quinoline N-oxide carrying a nitro substituent at position 4.	2	1	C-nitro compound; quinoline N-oxide	carcinogenic agent
bromodeoxyuridine Bromodeoxyuridine: A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors.	2.03	1	pyrimidine 2'-deoxyribonucleoside	antimetabolite; antineoplastic agent
4-butyrolactone 4-Butyrolactone: One of the FURANS with a carbonyl thereby forming a cyclic lactone. It is an endogenous compound made from gamma-aminobutyrate and is the precursor of gamma-hydroxybutyrate. It is also used as a pharmacological agent and solvent.. tetrahydrofuranone : Any oxolane having an oxo- substituent at any position on the tetrahydrofuran ring.. gamma-butyrolactone : A butan-4-olide that is tetrahydrofuran substituted by an oxo group at position 2.	2.03	1	butan-4-olide	metabolite; neurotoxin
silver Silver: An element with the atomic symbol Ag, atomic number 47, and atomic weight 107.87. It is a soft metal that is used medically in surgical instruments, dental prostheses, and alloys. Long-continued use of silver salts can lead to a form of poisoning known as ARGYRIA.	2.21	1	copper group element atom; elemental silver	Escherichia coli metabolite
4-nitropyridine [no description available]	1.97	1
penicillic acid Penicillic Acid: A mycotoxin with antibiotic and carcinogenic activity produced by various strains of PENICILLIUM and ASPERGILLUS. It has been found in tobacco, sausages, and corn.	2.03	1
homoserine lactone homoserine lactone: a putative signal for starvation in E. coli; structure in first source. homoserinium lactone : The conjugate acid of homoserine lactone; major species at pH 7.3.. homoserine lactone : A butan-4-olide having an amino substituent at the 2-position.	2.03	1	ammonium ion derivative; organic cation
furanone c-30 furanone C-30: structure in first source	2.03	1
nad NAD(1-) : An anionic form of nicotinamide adenine dinucleotide arising from deprotonation of the two OH groups of the diphosphate moiety.	2.38	2	organophosphate oxoanion	cofactor; human metabolite; hydrogen acceptor; Saccharomyces cerevisiae metabolite

Condition	Relationship Strength	Studies
Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.	2.03	1
Cancer of Mouth [description not available]	2.03	1
Condition, Preneoplastic [description not available]	2.03	1
Mouth Neoplasms Tumors or cancer of the MOUTH.	2.03	1
Precancerous Conditions Pathological conditions that tend eventually to become malignant.	2.03	1
Experimental Neoplasms [description not available]	1.95	1

chemdatabank.com